Clinical Trial Update: Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating switching osteoporosis patients from oral bisphosphonates to zoledronic acid has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED